Literature DB >> 18612030

Inappropriateness of using opioids for end-stage palliative sedation: a Dutch study.

R P B Reuzel1, G J Hasselaar, K C P Vissers, G J van der Wilt, J M M Groenewoud, B J P Crul.   

Abstract

To be able to distinguish end-stage palliative sedation from euthanasia without having to refer to intentions that are difficult to verify, physicians must be able to manage palliative sedation appropriately (i.e., see that death is not hastened as a result of disproportionate medication). In the present study, we assessed whether or not this requirement is met in the Netherlands. We sent a retrospective questionnaire to 1,464 medical specialists, general practitioners, and nursing home physicians in the Netherlands. Furthermore, we held two sets of 20 and 22 semi-structured in-depth interviews with general practitioners, internists, lung specialists, and nursing home physicians. Although most guidelines discourage the administration of opioids alone for purposes of palliative sedation, opioids alone were administered for 22% of all the patients reported upon. Those physicians who were more experienced, general practitioners, and physicians who had consulted a palliative care expert administered only opioids significantly less often than the other physicians. The interviewees reported difficulties in assessing the appropriateness of medication, feeling uncertain about the pharmacokinetics of drugs used in moribund patients. Given that no more than 2% of the respondents perceived palliative sedation to be used as a form of euthanasia and that the use of opioids alone was not associated with shorter survival rates, the inappropriate use of opioids can only be attributed to a lack of knowledge or skill and/or a tradition of alleviating refractory dyspnoea with the use of opioids and not as an intentional means of hastening death.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18612030     DOI: 10.1177/0269216308091867

Source DB:  PubMed          Journal:  Palliat Med        ISSN: 0269-2163            Impact factor:   4.762


  11 in total

Review 1.  [Sedation in palliative medicine: Guidelines for the use of sedation in palliative care : European Association for Palliative Care (EAPC)].

Authors:  B Alt-Epping; T Sitte; F Nauck; L Radbruch
Journal:  Schmerz       Date:  2010-08       Impact factor: 1.107

2.  Attitudes of palliative home care physicians towards palliative sedation at home in Italy.

Authors:  Sebastiano Mercadante; Francesco Masedu; Alessandro Mercadante; Franco Marinangeli; Federica Aielli
Journal:  Support Care Cancer       Date:  2017-01-17       Impact factor: 3.603

3.  A survey of the sedation practice of Portuguese palliative care teams.

Authors:  Ferraz Gonçalves; Aida Cordero; Ana Almeida; Arlindo Cruz; Céu Rocha; Madalena Feio; Paula Silva; Salomé Barbas; Sandra Neves
Journal:  Support Care Cancer       Date:  2012-03-24       Impact factor: 3.603

4.  Continuous Deep Sedation Until Death-a Swiss Death Certificate Study.

Authors:  Sarah Ziegler; Margareta Schmid; Matthias Bopp; Georg Bosshard; Milo Alan Puhan
Journal:  J Gen Intern Med       Date:  2018-03-20       Impact factor: 5.128

5.  Physicians' Experiences and Perceptions of Environmental Factors Affecting Their Practices of Continuous Deep Sedation until Death: A Secondary Qualitative Analysis of an Interview Study.

Authors:  Stijn Vissers; Sigrid Dierickx; Lenzo Robijn; Joachim Cohen; Luc Deliens; Freddy Mortier; Kenneth Chambaere
Journal:  Int J Environ Res Public Health       Date:  2022-04-30       Impact factor: 4.614

6.  Using continuous sedation until death for cancer patients: a qualitative interview study of physicians' and nurses' practice in three European countries.

Authors:  Jane Seymour; Judith Rietjens; Sophie Bruinsma; Luc Deliens; Sigrid Sterckx; Freddy Mortier; Jayne Brown; Nigel Mathers; Agnes van der Heide
Journal:  Palliat Med       Date:  2014-07-25       Impact factor: 4.762

Review 7.  The impact of the inpatient practice of continuous deep sedation until death on healthcare professionals' emotional well-being: a systematic review.

Authors:  Sarah Ziegler; Hannes Merker; Margareta Schmid; Milo A Puhan
Journal:  BMC Palliat Care       Date:  2017-05-08       Impact factor: 3.234

8.  Palliative sedation in Germany: factors and treatment practices associated with different sedation rate estimates in palliative and hospice care services.

Authors:  Stephanie Stiel; Mareike Nurnus; Christoph Ostgathe; Carsten Klein
Journal:  BMC Palliat Care       Date:  2018-03-13       Impact factor: 3.234

9.  Evidence for the use of Levomepromazine for symptom control in the palliative care setting: a systematic review.

Authors:  Isabel Dietz; Andrea Schmitz; Ingrid Lampey; Christian Schulz
Journal:  BMC Palliat Care       Date:  2013-01-19       Impact factor: 3.234

10.  A research study review of effectiveness of treatments for psychiatric conditions common to end-stage cancer patients: needs assessment for future research and an impassioned plea.

Authors:  Ralph J Johnson
Journal:  BMC Psychiatry       Date:  2018-04-03       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.